Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART program 2001 data

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 7, 2003, Pages 2152-2157

  Hsueh, Po Ren ^a   Teng, Lee Jene ^a   Lee, Chun Ming ^b   Huang, Wen Kuei ^e   Wu, Tsu Lan ^f   Wan, Jen Hsien ^g   Yang, Dine ^b   Shyr, Jainn Ming ^h   Chuang, Yin Ching ⁱ   Yan, Jing Jou ^j   Lu, Jang Jih ^c   Wu, Jiunn Jong ^j   Ko, Wen Chien ^j   Chang, Feng Yee ^c   Yang, Yi Chueh ⁱ   Lau, Yeu Jun ^h   Liu, Yung Ching ^e   Leu, Hsieh Shong ^f   Liu, Cheng Yi ^d   Luh, Kwen Tay ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^f CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^h TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

ⁱ CHI MEI MEDICAL CENTER   (Taiwan)

^j NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFEPIME; CEFOTAXIME; CEFPIROME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERTAPENEM; ERYTHROMYCIN; GATIFLOXACIN; GEMIFLOXACIN; IMIPENEM; LEVOFLOXACIN; LINCOSAMIDE DERIVATIVE; LINEZOLID; MACROLIDE; MEROPENEM; MIKAMYCIN B; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SITAFLOXACIN; TEICOPLANIN; TELITHROMYCIN; TETRACYCLINE DERIVATIVE; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; GEOGRAPHIC DISTRIBUTION; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES; TAIWAN;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENES, BACTERIAL; HUMANS; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TAIWAN; VIRGINIAMYCIN;

EID: 0038338387     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.7.2152-2157.2003     Document Type: Article

References (38)

1. Anderegg, T. R., D. J. Biedenbach, and R. N. Jones. 2002. In vitro evaluation of AZD2563, a new oxazolidinone, tested against beta-hemolytic and viridans group streptococci. J. Antimicrob. Chemother. 49:1019-1021.
2. Bemer-Melchior, P., M. Juvin, S. Tassin, A. Bryskier, G. C. Schito, and H. Drugeon. 2000. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors. Antimicrob. Agents Chemother. 44:2999-3002.
3. Betriu, C., C. Casado, M. Gomez, A. Sanchez, M. L. Palau, and J. J. Picazo. 1999. Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study. Diagn. Microbiol. Infect. Dis. 33:255-260.
4. Betriu, C., I. Rodriguez-Avial, B. A. Sanchez, M. Gomez, J. Alvarez, J. J. Picazo, and Spanish Group of Tigecycline. 2002. In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain. Antimicrob. Agents Chemother. 46:892-895.
5. Boucher, H. W., C. B. Wennersten, and G. M. Elipoulos. 2000. In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria. Antimicrob. Agents Chemother. 44:2225-2229.
6. Cornaglia, G., M. Ligozzi, A. Mazzariol, M. Valentini, G. Orefici, the Italian Surveillance Group for Antimicrobial Resistance, and R. Fontana. 1996. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. Emerg. Infect. Dis. 2:339-342.
7. Critchley, I. A., D. F. Sahm, C. Thornsberry, R. S. Blosser-Middleton, M. E. Jones, and J. A. Karlowsky. 2002. Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999. Diagn. Microbiol. Infect. Dis. 42:129-135.
8. Deshpande, L. M., A. C. Gales, and R. N. Jones. 2001. GAR-936 (9-butyl-glycylamido-minocycline) susceptibility test development for streptococci, Haemophilus influenzae and Neisseria gonorrhoeae: preliminary guidelines and interpretive criteria. Int. J. Antimicrob. Agents 18:29-35.
9. Esposito, S., S. Noviello, F. Ianniello, and A. Novelli. 2000. In vitro activity of moxifloxacin compared to other fluoroquinolones against different erythromycin-resistant phenotypes of group A beta-hemolytic streptococcus. Chemotherapy 46:23-27.
10. Felmingham, D. 2001. Microbiological profiles of telithromycin, the first ketolide antimicrobial. Clin. Microbiol. Infect. 7(Suppl. 3):2-10.
11. Giovanetti, E., M. P. Montanari, M. Mingoia, and P. E. Varaldo. 1999. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob. Agents Chemother. 43:1935-1940.
12. Giovanetti, E., A. Brenciani, R. Burioni, and P. E. Varaldo. 2002. A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes. Antimicrob. Agents Chemother. 46:3750-3755.
13. Gordon, K. A., M. L. Beach, D. J. Bledenbach, R. N. Jones, P. R. Rhomberg, and A. H. Mutnick. 2002. Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn. Microbiol. Infect. Dis. 43:157-162.
14. Hsueh, P.-R., H.-M. Chen, A.-H. Huang, and J.-J. Wu. 1995. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob. Agents Chemother. 61:3369-3374.
15. Hsueh, P.-R., J.-J. Wu, P.-J. Tsai, J.-W. Liu, Y.-C. Chuang, and K.-T. Luh. 1998. Invasive group A streptococcal disease in Taiwan is not associated with the presence of streptococcal pyrogenic exotoxin genes. Clin. Infect. Dis. 26:584-589.
16. Hsueh, P.-R., L.-J. Teng, T.-L. Wu, D. Yang, W.-K. Huang, J.-M. Shyr, Y.-C. Chuang, J.-H. Wan, J.-J. Yan, J.-J. Lu, J.-J. Wu, W.-C. Ko, F.-Y. Chang, Y.-C. Yang, Y.-J. Lau, Y.-C. Liu, C.-M. Lee, H.-S. Leu, C.-Y. Liu, and K.-T. Luh. 2003. Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and β-lactams: SMART program 2001 data. Antimicrob. Agents Chemother. 47:2145-2151.
17. Hsueh, P.-R., C.-Y. Liu, and K.-T. Luh. 2000. Current status of antimicrobial resistance in Taiwan. Emerg. Infect. Dis. 8:132-137.
18. Hsueh, P.-R., L.-J. Teng, L.-N. Lee, P.-C. Yang, S.-W. Ho, H.-C. Lue, and K.-T. Luh. 2002. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan. Microb. Drug Resist. 8:27-33.
19. Jalava, J., J. Kataja, H. Seppala, and P. Huovinen. 2001. In vitro activities of the novel telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob. Agents Chemother. 45:789-793.
20. Kataja, J., P. Huovinen, M. Skurnik, The Finnish Study Group for Antimicrobial Resistance, and H. Seppala. 1999. Erythromycin resistance genes in group A streptococci in Finland. Antimicrob. Agents Chemother. 43:48-52.
21. Kozlov, R. S., T. M. Bogdanovitch, P. C. Appelbaum, L. Ednie, L. S. Stratchounski, M. R. Jacobs, and B. Bozdogan. 2002. Antistreptococcal activity of telithromycin compared with seven other drugs in relation to macrolide resistance mechanisms in Russia. Antimicrob. Agents Chemother. 46:2963-2968.
22. Leclercq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1267-1272.
23. Luh, K.-T., P.-R. Hsueh, L.-J. Teng, H.-J. Pan, Y.-C. Chen, J.-J. Lu, J.-J. Wu, and S.-W. Ho. 2000. Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan. Antimicrob. Agents Chemother. 44:3374-3380.
24. Milatovic, D., F. Schmitz, S. Brisse, J. Verhoef, and A. C. Fluit. 2000. In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates. Antimicrob. Agents Chemother. 44:1102-1107.
25. Nagai, K., P. C. Appelbaum, T. A. Davies, L. M. Kelly, D. B. Hoellman, A. T. Andrasevic, L. Drukalska, W. Hryniewicz, M. R. Jacobs, J. Kolman, J. Miciuleviciene, M. Pana, L. Setchanova, M. K. Thege, H. Hupkova, J. Trupl, and P. Urbaskova. 2002. Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and eastern European countries. Antimicrob. Agents Chemother. 46:546-549.
26. Nagai, K., T. A. Davies, L. M. Ednie, A. Bryskier, E. Palavecino, M. R. Jacobs, and P. C. Appelbaum. 2001. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. Antimicrob. Agents Chemother. 45:3242-3245.
27. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standards, 5th ed. M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
28. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing: 12th informational supplement. M100-S12. National Committee for Clinical Laboratory Standards, Wayne, Pa.
29. Sauermann, R., R. Gattringer, W. Graninger, A. Buxbaum, and A. Georgopoulos. 2003. Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics. J. Antimicrob. Chemother. 51:53-57.
30. Seppala, H., A. Nissinen, H. Jarvinen, S. Huovinen, T. Henriksson, E. Herva, S. E. Holm, M. Jahkola, M. Katila, T. Klaukka, S. Kontiainen, O. Liimatainen, S. Oinonen, L. Passi-Metsomaa, and P. Huovinen. 1992. Resistance to erythromycin in group A streptococci. N. Engl. J. Med. 326:292-297.
31. Seppala, H., A. Nissinen, Q. Yu, and P. Huovinen. 1993. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32:885-891.
32. Seppala, H., M. Skurnik, H. Suini, M. C. Roberts, and P. Huovinen. 1998. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:257-262.
33. Shortridge, V. D., P. Zhong, Z. Cao, J. M. Beyer, L. S. Almer, N. C. Ramer, S. Z. Doktor, and R. K. Flamm. 2002. Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci. Antimicrob. Agents Chemother. 46:783-786.
34. Sutcliffe, J., A. Tait-Karmadt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
35. Sutcliffe, J., T. Grebe, A. Tait-Karmadt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
36. Weiss, K., J. De Azavedo, C. Restieri, L. A. Galarneau, M. Gourdeau, P. Harvey, J. F. Paradis, K. Salim, and D. E. Low. 2001. Phenotypic and genotypic characterization of macrolide-resistant group A Streptococcus strains in the province of Quebec, Canada. J. Antimicrob. Chemother. 47:345-348.
37. Yan, J.-J., H.-M. Wu, A.-H. Huang, H.-M. Fu, C.-T. Lee, and J.-J. Wu. 2000. Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in southern Taiwan. J. Clin. Microbiol. 38:2475-2479.
38. Zampaloni, C., L. A. Vitali, M. Prenna, M. A. Toscano, G. Tempera, and S. Ripa. 2002. Erythromycin resistance in Italian isolates of Streptococcus pyogenes and correlations with pulsed-field gel electrophoresis analysis. Microb. Drug Resist. 8:39-44.